세계의 유전체 편집/유전체 공학 시장 보고서(2025년)

Genome editing is a technique that allows scientists to modify the DNA of various organisms, including plants, bacteria, and animals. This technology enables the alteration of DNA, influencing physical characteristics such as eye color and the susceptibility to diseases. Genome editing is extensively used in research labs with animal models and cells to gain insights into diseases.

The main products and services in genome editing and genome engineering encompass reagents and consumables, software and systems, and services. Reagents and consumables are utilized at specific locations in the genome of a target organism to induce breaks, repairs, or mismatches, leveraging endogenous mechanisms to bring about specific changes in the DNA sequence. Consumables are items used until depletion and then disposed of, while reagents are compounds or substances that facilitate a reaction. Various technologies, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nucleases (ZFN), antisense, and others, are employed in genome editing. These technologies find applications in cell line engineering, genetic engineering, diagnostic applications, drug discovery and development, and various other fields. The users of genome editing technologies include biotechnology companies, pharmaceutical companies, academic and government research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genome editing or genome engineering market research report is one of a series of new reports from The Business Research Company that provides genome editing or genome engineering market statistics, including genome editing or genome engineering industry global market size, regional shares, competitors with a genome editing or genome engineering market share, detailed genome editing or genome engineering market segments, market trends and opportunities, and any further data you may need to thrive in the genome editing or genome engineering industry. This genome editing or genome engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genome editing/genome engineering market size has grown rapidly in recent years. It will grow from $8.62 billion in 2024 to $10.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to increasing research in genetics and genomics, rise in genetic diseases, gene therapy advancements, investments in biotechnology and life sciences, potential for agricultural applications, application in model organisms.

The genome editing/genome engineering market size is expected to see rapid growth in the next few years. It will grow to $20.64 billion in 2029 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to emergence of prime editing, focus on ethical and regulatory frameworks, increasing adoption in drug discovery, therapeutic potential for genetic disorders, customization for gene function studies, growing interest in epigenome editing. Major trends in the forecast period include advancements in Crispr technology, growing applications in therapeutics, emergence of new genome editing tools, investments and partnerships, enhanced delivery systems, integration of artificial intelligence (AI) in genome editing design.

The forecast of 19.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision gene therapies by inflating prices of Clustered regularly interspaced short palindromic repeats(CRISPR)-Cas9 systems and gene editing reagents developed in China and Sweden, resulting in delayed rare disease treatments and higher genetic research costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer and other genetic disorders is anticipated to drive the growth of the genome editing and genome engineering market in the future. Cancer is a condition characterized by the uncontrolled growth of certain cells in the body, which can spread to other areas. Genome editing has the potential to rapidly engineer immune cells and oncolytic viruses for therapeutic purposes in cancer treatment. For instance, in February 2022, an article published by the World Health Organization (WHO), a Switzerland-based agency of the United Nations, reported that nearly 10 million deaths, or approximately one in six deaths, were attributed to cancer, making it the leading cause of death globally. Additionally, a June 2022 report from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, indicated that 1,752,735 new cases of invasive cancer were diagnosed in the US in 2019, including 863,830 women and 888,905 men. The overall incidence rate for all cancers was 439 per 100,000 individuals in the general population. Therefore, the rising prevalence of cancer and other genetic disorders is propelling the growth of the genome editing and genome engineering market.

An anticipated rise in research activities is set to propel the growth of the genome editing and genome engineering market in the future. Research activities involve systematic and organized efforts by individuals, teams, or institutions aimed at gathering, analyzing, interpreting, and generating new knowledge or insights within a specific field. Genome editing and genome engineering have emerged as pivotal drivers of the increasing research landscape, significantly reshaping scientific exploration. These groundbreaking tools enable researchers to precisely modify and understand the complex genetic structures of organisms, providing unmatched accuracy and flexibility. For example, in February 2024, The Office for National Statistics, a UK-based agency, reported that in 2022, UK businesses invested £49.9 billion ($65.29 billion) in research and development (R&D), marking an increase of £3.0 billion ($3.93 billion) or 6.4% compared to 2021. Consequently, the rise in research activities is fueling the growth of the genome editing and genome engineering market.

The genome editing or genome engineering market is witnessing a key trend in technological advancements in gene editing. Major companies are focusing on developing innovative technology solutions to enhance their position in the market. For instance, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra) have introduced a novel gene-editing method called Direct Parental CRISPR (DIPA-CRISPR). This technique offers a quick and effective means of editing genes in insects by injecting materials into developing eggs in female adults, bypassing the traditional method of microinjecting CRISPR material into insect embryos. The adoption of advanced gene-editing technologies is contributing to the efficiency and precision of genetic modifications.

Major companies operating in the genome editing or genome engineering market are engaging in strategic partnerships to fortify their positions. Strategic partnerships, such as the collaboration between Ionis Pharmaceuticals Inc. and Metagenomi, aim to expand and diversify technological capabilities. Ionis Pharmaceuticals Inc., a biotechnology company, partnered with Metagenomi, a genomic medicines company, to leverage their respective technologies and deliver transformative therapies focused on genetic targets. Such collaborations enable companies to pool resources, share expertise, and innovate collectively, fostering advancements in the genome editing or genome engineering field.

In September 2022, Lesaffre, a France-based microorganisms, healthcare and biotechnology company acquired Recombia Biosciences for an undisclosed amount. The acquisition aims to leverage Recombia Biosciences' genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. Recombia Biosciences is a US-based biotechnology company.

Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

North America was the largest region in the gene editing or genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing or genome engineering market report during the forecast period. The regions covered in the genome editing or genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genome editing or genome engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genome editing or genome engineering market includes revenues earned by entities through cell line engineering, animal genetic engineering, and plant genetic engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genome Editing/Genome Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genome editing/genome engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome editing/genome engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genome editing/genome engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Reagents And Consumables; Software And systems; Services
• 2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
• 3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
• 4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
• Subsegments:
• 1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents
• 2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems
• 3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Group; Genscript Biotech Corp; Sangamo Therapeutics Inc.; Lonza Group AG; Editas Medicine Inc.; CRISPR Therapeutics AG; Agilent Technologies Inc.; Intellia Therapeutics; bluebird bio Inc.; Transposagen Biopharmaceuticals Inc.; Tecan Trading AG; Precision BioSciences; PerkinElmer Inc.; Cellectis S.A; Applied StemCell Inc.; Bio-Rad Laboratories Inc.; Bio-Techne; Creative Biogene; Cyagen Biosciences; Dharmacon Inc.; Eurofins Genomics LLC; Evotec SE; GeneCopoeia Inc.; Genewiz; Horizon Discovery Group PLC; Inscripta Inc.; Integrated DNA Technologies Inc.; MaxCyte Inc.; New England Biolabs; Novartis International AG.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genome Editing/Genome Engineering Market Characteristics

3. Genome Editing/Genome Engineering Market Trends And Strategies

4. Genome Editing/Genome Engineering Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genome Editing/Genome Engineering Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genome Editing/Genome Engineering PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genome Editing/Genome Engineering Market Growth Rate Analysis
• 5.4. Global Genome Editing/Genome Engineering Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genome Editing/Genome Engineering Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genome Editing/Genome Engineering Total Addressable Market (TAM)

6. Genome Editing/Genome Engineering Market Segmentation

• 6.1. Global Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Software And systems
• Services
• 6.2. Global Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR
• TALEN
• ZFN
• Antisense
• Other Technologies
• 6.3. Global Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Line Engineering
• Genetic Engineering
• Diagnostic Applications
• Drug Discovery And Development
• Other Applications
• 6.4. Global Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Academic And Government Research Institutes
• 6.5. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Or Cas9 Kits
• TALENs Kits
• Zinc Finger Nucleases (ZFNs)
• Donor DNA Templates
• Nucleotide Reagents
• 6.6. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Software And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genome Editing Design Software
• Analysis And Visualization Tools
• Workflow Management Systems
• 6.7. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Synthesis And Cloning Services
• Custom Genome Editing Services
• Consulting Services For Genome Editing Projects

7. Genome Editing/Genome Engineering Market Regional And Country Analysis

• 7.1. Global Genome Editing/Genome Engineering Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genome Editing/Genome Engineering Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genome Editing/Genome Engineering Market

• 8.1. Asia-Pacific Genome Editing/Genome Engineering Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genome Editing/Genome Engineering Market

• 9.1. China Genome Editing/Genome Engineering Market Overview
• 9.2. China Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genome Editing/Genome Engineering Market

• 10.1. India Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genome Editing/Genome Engineering Market

• 11.1. Japan Genome Editing/Genome Engineering Market Overview
• 11.2. Japan Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genome Editing/Genome Engineering Market

• 12.1. Australia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genome Editing/Genome Engineering Market

• 13.1. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genome Editing/Genome Engineering Market

• 14.1. South Korea Genome Editing/Genome Engineering Market Overview
• 14.2. South Korea Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genome Editing/Genome Engineering Market

• 15.1. Western Europe Genome Editing/Genome Engineering Market Overview
• 15.2. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genome Editing/Genome Engineering Market

• 16.1. UK Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genome Editing/Genome Engineering Market

• 17.1. Germany Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genome Editing/Genome Engineering Market

• 18.1. France Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genome Editing/Genome Engineering Market

• 19.1. Italy Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genome Editing/Genome Engineering Market

• 20.1. Spain Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genome Editing/Genome Engineering Market

• 21.1. Eastern Europe Genome Editing/Genome Engineering Market Overview
• 21.2. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genome Editing/Genome Engineering Market

• 22.1. Russia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genome Editing/Genome Engineering Market

• 23.1. North America Genome Editing/Genome Engineering Market Overview
• 23.2. North America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genome Editing/Genome Engineering Market

• 24.1. USA Genome Editing/Genome Engineering Market Overview
• 24.2. USA Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genome Editing/Genome Engineering Market

• 25.1. Canada Genome Editing/Genome Engineering Market Overview
• 25.2. Canada Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genome Editing/Genome Engineering Market

• 26.1. South America Genome Editing/Genome Engineering Market Overview
• 26.2. South America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genome Editing/Genome Engineering Market

• 27.1. Brazil Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genome Editing/Genome Engineering Market

• 28.1. Middle East Genome Editing/Genome Engineering Market Overview
• 28.2. Middle East Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genome Editing/Genome Engineering Market

• 29.1. Africa Genome Editing/Genome Engineering Market Overview
• 29.2. Africa Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genome Editing/Genome Engineering Market Competitive Landscape And Company Profiles

• 30.1. Genome Editing/Genome Engineering Market Competitive Landscape
• 30.2. Genome Editing/Genome Engineering Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Genscript Biotech Corp Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Genome Editing/Genome Engineering Market Other Major And Innovative Companies

• 31.1. Editas Medicine Inc.
• 31.2. CRISPR Therapeutics AG
• 31.3. Agilent Technologies Inc.
• 31.4. Intellia Therapeutics
• 31.5. bluebird bio Inc.
• 31.6. Transposagen Biopharmaceuticals Inc.
• 31.7. Tecan Trading AG
• 31.8. Precision BioSciences
• 31.9. PerkinElmer Inc.
• 31.10. Cellectis S.A
• 31.11. Applied StemCell Inc.
• 31.12. Bio-Rad Laboratories Inc.
• 31.13. Bio-Techne
• 31.14. Creative Biogene
• 31.15. Cyagen Biosciences

32. Global Genome Editing/Genome Engineering Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genome Editing/Genome Engineering Market

34. Recent Developments In The Genome Editing/Genome Engineering Market

35. Genome Editing/Genome Engineering Market High Potential Countries, Segments and Strategies

• 35.1 Genome Editing/Genome Engineering Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genome Editing/Genome Engineering Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genome Editing/Genome Engineering Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer